Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Perrotti

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Research|March 15, 1997
Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene familyR Martinez, D Venturelli, D Perrotti, et al.
Experimental Cell Research|March 31, 2000
The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expressionL Manzella, R Gualdi, D Perrotti, et al.
Cancer Research|June 1, 1995
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesisT Skorski, M Nieborowska-Skorska, C Szczylik, et al.
Oncogene|February 24, 2009
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patientsA K Samanta, S N Chakraborty, Y Wang, et al.
Molecular and Cellular Biology|July 27, 2000
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathwayD Perrotti, A Iervolino, V Cesi, et al.
Blood|April 16, 1998
Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cellsM Z Ratajczak, D Perrotti, P Melotti, et al.
The EMBO Journal|August 4, 1998
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesisD Perrotti, S Bonatti, R Trotta, et al.
Journal of the National Cancer Institute|January 15, 1997
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotidesT Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Leukemia|July 31, 2009
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issuesJ M Goldman, A R Green, T Holyoake, et al.
The EMBO Journal|October 8, 1997
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathwayT Skorski, A Bellacosa, M Nieborowska-Skorska, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Research|March 15, 1997
Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene familyR Martinez, D Venturelli, D Perrotti, et al.
Experimental Cell Research|March 31, 2000
The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expressionL Manzella, R Gualdi, D Perrotti, et al.
Cancer Research|June 1, 1995
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesisT Skorski, M Nieborowska-Skorska, C Szczylik, et al.
Oncogene|February 24, 2009
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patientsA K Samanta, S N Chakraborty, Y Wang, et al.
Molecular and Cellular Biology|July 27, 2000
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathwayD Perrotti, A Iervolino, V Cesi, et al.
Blood|April 16, 1998
Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cellsM Z Ratajczak, D Perrotti, P Melotti, et al.
The EMBO Journal|August 4, 1998
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesisD Perrotti, S Bonatti, R Trotta, et al.
Journal of the National Cancer Institute|January 15, 1997
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotidesT Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Leukemia|July 31, 2009
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issuesJ M Goldman, A R Green, T Holyoake, et al.
The EMBO Journal|October 8, 1997
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathwayT Skorski, A Bellacosa, M Nieborowska-Skorska, et al.
Pageof 4